Saturday 6 November 2021, 9.30am - 12.30pm
Addiction medicine physicians, general practitioners, nurse practitioners, and other practitioners prescribing or intending to prescribe s85 DAA medication for HCV in alcohol and other drug settings in Australia.
By the end of this training, participants will be able to:
This course will be delivered in three parts
Part 1 consists of a 1.5-hour eLearning component introducing the learner to assessment, management and treatment of hepatitis C in drug and alcohol settings.
Part 2 consists of a 3-hour interactive online training session building on the knowledge and skills gained in Part 1 through practical case discussions.
Part 3 consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.